Author

Vatsalya Vatsalya

Assistant Professor of Medicine, University of Louisville, and the Robley Rex VA Medical Center - Cited by 934 - Novel Alcohol Human Mechanistic Paradigm - Treatment Assessment of Alcoholism - Gut-Brain Circuit - Organ Injury - Viral Comobidi

Biography

Vatsalya Vatsalya is currently working as a Faculty at the University of Louisville, and Scientist at the Robley Rex VA Medical Center; he extended his valuable service in field of Pharmacology and Toxicology for several years and has been a recipient of few awards and grants. His research interests reflect in his wide range of publications in various national and international journals.
Title
Cited by
Year
Repurposing treatment of Wernicke–Korsakoff syndrome for Th-17 cell immune storm syndrome and neurological symptoms in COVID-19: thiamine efficacy and safety, in-vitro evidence …
V Vatsalya, F Li, J Frimodig, KS Gala, S Srivastava, M Kong, ...Frontiers in Pharmacology 11, 598128, 202135202
35
2021
Inhibition of sphingosine‐1‐phosphate‐induced Th17 cells ameliorates alcohol‐associated steatohepatitis in mice
S Chu, R Sun, X Gu, L Chen, M Liu, HX Guo, S Ju, V Vatsalya, W Feng, ...Hepatology 73 (3), 952-967, 2021202
24
2021
Characterization of early-stage alcoholic liver disease with hyperhomocysteinemia and gut dysfunction and associated immune response in alcohol use disorder patients
V Vatsalya, KS Gala, AZ Hassan, J Frimodig, M Kong, N Sinha, ...Biomedicines 9 (1), 7, 2020202
12
2020
Linoleic Acid‐Derived Oxylipins Differentiate Early Stage Alcoholic Hepatitis From Mild Alcohol‐Associated Liver Injury
D Warner, V Vatsalya, KH Zirnheld, JB Warner, JE Hardesty, JC Umhau, ...Hepatology Communications 5 (6), 47-60, 2021202
9
2021
Metabolic profiling of bile acids in the urine of patients with alcohol‐associated liver disease
L He, V Vatsalya, X Ma, J Zhang, X Yin, S Kim, W Feng, CJ McClain, ...Hepatology Communications 5 (5), 798-811, 20217202
7
2021
Keratin-18: Diagnostic, Prognostic and Theragnostic for Alcohol-Associated Hepatitis
CJ McClain, V Vatsalya, MC MitchellThe American journal of gastroenterology 11 (1), 77, 2021202
6
2021
Probiotic‐derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation
M Jiang, F Li, Y Liu, Z Gu, L Zhang, J Lee, L He, V Vatsalya, HG Zhang, ...Hepatology, 2022202
6
2022
Influence of age and sex on alcohol pharmacokinetics and subjective pharmacodynamic responses following intravenous alcohol exposure in humans
V Vatsalya, ND Byrd, BL Stangl, R Momenan, VA RamchandaniAlcohol 107, 1-152, 2023202
4
2023
Efficacy of Thiamine and Medical Management in Treating Hyperuricemia in AUD Patients with ALD: Role of Hyperuricemia in Liver Injury, Gut-Barrier Dysfunction, and Inflammation
V Vatsalya, F Li, J Frimodig, N Shah, A Sutrawe, W FengClinical & experimental pharmacology 11 (Suppl 7), 20214202
4
2021
Positive blood phosphatidylethanol concentration is associated with unfavorable waitlist‐related outcomes for patients medically appropriate for liver transplantation
CS Faulkner, CM White, W Manatsathit, B Lamb, V Vatsalya, CJ McClain, ...Alcoholism: Clinical and Experimental Research 46 (4), 581-588, 2022202
3
2022
Interaction of heavy drinking patterns and depression severity predicts efficacy of quetiapine fumarate XR in lowering alcohol intake in alcohol use disorder patients
V Vatsalya, M Kong, LM Marsano, Z Kurlawala, KV Chandras, ...Substance abuse: research and treatment 14, 1178221820955185, 2020202
3
2020
Theragnostic efficacy of K18 response in alcohol use disorder with clinically significant fibrosis using gut-liver axis
M Sagaram, R Parthasarathy, SL Condon, CF Closson, M Kong, ...International Journal of Molecular Sciences 2 (10), 5852, 2022202
3
2022
Association of hypomagnesemia and liver injury, role of gut-barrier dysfunction and inflammation: efficacy of abstinence, and 2-week medical management in alcohol use disorder …
EJ Winrich, KS Gala, A Rajhans, CD Rios-Perez, AJ Royer, Z Zamani, ...International Journal of Molecular Sciences 2 (19), 112, 2022202
3
2022
Prevalence and Treatment for Alcohol Use Disorders Based on Kentucky Medicaid 2012–2019 Datasets
Prevalence and Treatment for Alcohol Use Disorders Based on Kentucky Medicaid 01–019 DatasetsH Hu, R Mitra, Y Han, S Pal, H Huang, CJ McClain, V Vatsalya, ...Journal of alcoholism and drug dependence 10 (5), 0
2
2022
Metabolomics analysis of urine from patients with alcohol-associated liver disease reveals dysregulated caffeine metabolism
R Xu, L He, V Vatsalya, X Ma, S Kim, EG Mueller, W Feng, CJ McClain, ...American Journal of Physiology-Gastrointestinal and Liver Physiology 34 ( …, 030
2
2023
The Beneficial Effects of Lactobacillus GG Therapy on Liver and Drinking Assessments in Patients with Moderate Alcohol-Associated Hepatitis.
V Vatsalya, W Feng, M Kong, H Hu, G Szabo, A McCullough, S Dasarathy, ...American Journal of Gastroenterology, -2, 2023202
1
2023
Blood phosphatidylethanol (PEth) positivity associates with unfavorable waitlist-related outcomes for patients medically appropriate for liver transplant
CS Faulkner, CM White, W Manatsathit, B Lamb, V Vatsalya, CJ McClain, ...Alcoholism, clinical and experimental research 46 (4), 58, 2022202
1
2022
Elevated stearoyl-coA desaturase 1 activity is associated with alcohol-associated liver disease
Elevated stearoyl-coA desaturase activity is associated with alcohol-associated liver diseaseTD Klepp, ME Sloan, S Soundararajan, CE Ramsden, R Cinar, ...Alcohol 02, 5-57, 2022202
1
2022
Metabolic Analysis of Nucleosides/Bases in the Urine and Serum of Patients with Alcohol-Associated Liver Disease
L He, V Vatsalya, X Ma, CM Klinge, MC Cave, W Feng, CJ McClain, ...Metabolites 2 (2), 87, 2022202
1
2022
Dilemma of treating psychosis secondary to stroke
R Agrawal, S Verma, V Vatsalya, M Halappanavar, K OrakaCureus 3 (), 20220
1
2021

Referred From: https://scholar.google.com/citations?user=Rxj9kHQAAAAJ&hl=en

Cited by
Citations 934
h-index 19
i10-index 28
Recommended Journals
Open Access Journals